MAPK3 and gastric neoplasm: After analyzing genomic DNA from 104 gastric tumors, Yoo et al. (2002) found that RAS mutations are uncommon among gastric adenocarcinomas, but that elevated ERK1/2 activity was a characteristic of invasive tumors 34.